The Fly | HNGE

Hinge Health, Inc. Class A

· HNGE

Dashboard

Financials

Ratios

Transcripts

Valuation

Tuesday

Hinge Health price target raised by $10 at Wells Fargo, here's why

HNGE

Jun 23, 5:26 PM

Monday

Omada Health has 'catch up potential,' says Morgan Stanley

Jun 22, 8:31 AM

Over a week ago

Hinge Health price target raised by $10 at Baird, here's why

HNGE

Jun 17, 6:16 AM

Hinge Health price target raised by $10 at Raymond James, here's why

HNGE

Jun 15, 7:34 AM

Hinge Health price target raised by $11 at Canaccord, here's why

HNGE

Jun 15, 6:36 AM

Hinge Health price target raised by $15 at KeyBanc, here's why

HNGE

Jun 12, 6:33 AM

Hinge Health price target raised by $6 at Truist, here's why

HNGE

Jun 11, 9:40 AM

Hinge Health price target raised by $10 at RBC Capital, here's why

HNGE

Jun 11, 9:01 AM

Hinge Health price target raised by $13 at Needham, here's why

HNGE

Jun 11, 7:15 AM

Hinge Health price target raised by $8 at Barclays, here's why

HNGE

Jun 11, 5:25 AM

What You Missed On Wall Street On Tuesday

+24

Jun 10, 4:27 PM

Midday Fly By: SpaceX IPO oversubscribed, Chewy reports in-line Q1

+24

Jun 10, 12:06 PM

Hinge Health adds orthopedic surgery to HingeSelect

HNGE

Jun 10, 9:24 AM

Video: Cracker Barrel advances after beat and raise report

Jun 10, 9:14 AM

Morning Movers: Dianthus plummets after peer Sanofi halts trial

Jun 10, 8:56 AM

Hinge Health price target raised by $12 at Stifel, here's why

HNGE

Jun 10, 6:37 AM

Hinge Health raises Q2 revenue view to $200M-$202M, consensus $194.95M

HNGE

Jun 10, 6:37 AM

Hinge Health raises FY26 revenue view to $818M-$824M, consensus $801.58M

HNGE

Jun 10, 6:37 AM

Hinge Health price target raised by $2 at Canaccord, here's why

HNGE

Jun 4, 6:53 AM

Hinge Health announces results of claims analysis of digital MSK solution

HNGE

Jun 3, 9:22 AM

Hinge Health price target raised by $4 at Needham, here's why

HNGE

May 6, 9:37 AM

Hinge Health price target raised by $16 at Truist, here's why

HNGE

May 6, 9:30 AM

Hinge Health price target raised by $15 at Raymond James

HNGE

May 6, 9:22 AM

Hinge Health price target raised by $15 at Raymond James, here's why

HNGE

May 6, 8:58 AM

Hinge Health price target raised by $35 at Piper Sandler, here's why

HNGE

May 6, 8:39 AM

Specialized MSK Focus: Deep expertise in musculoskeletal care addresses a high-cost and prevalent health issue for employers and payers, allowing for a targeted and effective solution.

Clinically Validated Outcomes: Extensive clinical research and published studies demonstrate the efficacy of their programs in reducing pain, avoiding surgeries, and lowering healthcare costs, building strong trust with clients.

Hybrid Care Delivery Model: Combines the scalability and accessibility of a digital platform with personalized human coaching (physical therapists, health coaches) to offer comprehensive and engaging support.

Intense Competition Affects Market Share and Pricing: The digital health market is crowded with various solutions for musculoskeletal (MSK) care, making it challenging for Hinge Health to differentiate and maintain competitive pricing.

Regulatory Compliance and Healthcare Law Changes Pose Risks: Operating in the highly regulated healthcare sector means potential issues with HIPAA, state medical licensing, data privacy laws, and evolving healthcare policies could result in fines or operational disruptions.

Data Security Breaches Could Undermine Trust and Operations: Handling sensitive patient health information makes the company a target for cyberattacks, with potential for data breaches, reputational damage, legal liabilities, and loss of client confidence.

Charts

Specialized MSK Focus: Deep expertise in musculoskeletal care addresses a high-cost and prevalent health issue for employers and payers, allowing for a targeted and effective solution.